Details for 2019161002
Up to date per 02.04.2026
Actions
Details for 2019161002
Granted/Registered
European Patent
31.07.2019 A
08.09.2021 B1
18.05.2011
US
201161487612 P
G01N 33/53 20060101AFI20190403BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, OsakaJP
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
Weber, AlfredSkraupstraße 24/42/8 1210 WienAT
Engelmaier, AndreaBenedikt-Schellinger-Gasse 17/25 1150 WienAT
Schwarz, Hans-PeterWeimarer Straße 76 1180 WienAT
Information about Fees